Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis

Published:2023-06 Issue:6 Volume:9 Page:e16704
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Gao Qin,Zhao Yanxia,Zhang Junling

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference28 articles.

1. Annoying psoriasis and atopic dermatitis: a narrative review;Chen;Int. J. Mol. Sci.,2022

2. Once-daily abrocitinib for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents aged 12 years and over: a short review of current clinical perspectives;Niculet;Therapeut. Clin. Risk Manag.,2022

3. The epidemiology and global burden of atopic dermatitis: a narrative review;Hadi;Life-Basel,2021

4. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease;Bieber;Nat. Rev. Drug Discov.,2022

5. Novel therapeutic approaches and targets for the treatment of atopic dermatitis;Pescitelli;Curr. Pharmaceut. Biotechnol.,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Human Esophageal Epithelial and Muscle Cells Treated With Th2 Cytokines, Upadacitinib Decreases Eotaxin-3 Secretion and Muscle Tension;Gastroenterology;2024-06

2. A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis;Dermatology and Therapy;2024-05-30

3. Plant-based zinc nanoflowers assisted molecularly imprinted polymer for the design of an electrochemical sensor for selective determination of abrocitinib;Microchimica Acta;2024-05-10

4. Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials;Expert Opinion on Emerging Drugs;2024-04-28

5. Current and emerging drugs for the treatment of pruritus: an update of the literature;Expert Opinion on Pharmacotherapy;2024-04-12